Literature DB >> 8508777

Poly(A) signals and transcriptional pause sites combine to prevent interference between RNA polymerase II promoters.

J Eggermont1, N J Proudfoot.   

Abstract

Transcriptional termination by RNA polymerase II at the 3' end of genes encoding poly(A)+ mRNAs is thought to require two distinct cis-active elements: a functional poly(A) signal and a downstream transcriptional pause site. An important requirement for efficient termination is to prevent transcriptional interference of downstream-located promoters. We have therefore investigated whether these two elements, individually or in combination, can prevent transcriptional interference of RNA polymerase II-activated promoters. For this purpose, we constructed an expression plasmid containing two tandem retroviral long terminal repeats (LTRs) derived from HIV-1. When transfected into HeLa cells, this construct resulted in transcriptional interference of the LTR promoters. Using this assay, we were able to show that a single poly(A) signal was able to protect an otherwise occluded promoter. This effect depended on the RNA-processing strength of the poly(A) signal. Furthermore, transcriptional pause sites provided adequate protection against promoter occlusion even when tested alone. Finally, a combined element consisting of a poly(A) signal followed by a pause site was more efficient in promoter protection than either element on its own. These results indicate that an interference-blocking element can take various forms: a poly(A) signal, a transcriptional pause site or a combination of both.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8508777      PMCID: PMC413492          DOI: 10.1002/j.1460-2075.1993.tb05909.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  44 in total

1.  An RNA polymerase I termination site can stimulate the adjacent ribosomal gene promoter by two distinct mechanisms in Xenopus laevis.

Authors:  B McStay; R H Reeder
Journal:  Genes Dev       Date:  1990-07       Impact factor: 11.361

Review 2.  News from the nucleolus: rRNA gene expression.

Authors:  B Sollner-Webb; E B Mougey
Journal:  Trends Biochem Sci       Date:  1991-02       Impact factor: 13.807

Review 3.  Regulation of HIV-1 gene expression.

Authors:  W C Greene
Journal:  Annu Rev Immunol       Date:  1990       Impact factor: 28.527

Review 4.  Transcription elongation and eukaryotic gene regulation.

Authors:  C A Spencer; M Groudine
Journal:  Oncogene       Date:  1990-06       Impact factor: 9.867

5.  RNA polymerase II transcription termination is mediated specifically by protein binding to a CCAAT box sequence.

Authors:  S Connelly; J L Manley
Journal:  Mol Cell Biol       Date:  1989-11       Impact factor: 4.272

6.  Interaction in vivo between strong closely spaced constitutive promoters.

Authors:  B Hausler; R L Somerville
Journal:  J Mol Biol       Date:  1979-01-25       Impact factor: 5.469

7.  Interaction of enhancer-binding protein EBP1 (NF-kappa B) with the human immunodeficiency virus type 1 enhancer.

Authors:  L Clark; J R Matthews; R T Hay
Journal:  J Virol       Date:  1990-03       Impact factor: 5.103

8.  Transcriptional interference in avian retroviruses--implications for the promoter insertion model of leukaemogenesis.

Authors:  B R Cullen; P T Lomedico; G Ju
Journal:  Nature       Date:  1984 Jan 19-25       Impact factor: 49.962

9.  An apparent pause site in the transcription unit of the rabbit alpha-globin gene.

Authors:  D J Vandenbergh; M James-Pederson; R C Hardison
Journal:  J Mol Biol       Date:  1991-07-20       Impact factor: 5.469

10.  A pause site for RNA polymerase II is associated with termination of transcription.

Authors:  P Enriquez-Harris; N Levitt; D Briggs; N J Proudfoot
Journal:  EMBO J       Date:  1991-07       Impact factor: 11.598

View more
  51 in total

1.  The formamidase gene of Aspergillus nidulans: regulation by nitrogen metabolite repression and transcriptional interference by an overlapping upstream gene.

Authors:  J A Fraser; M A Davis; M J Hynes
Journal:  Genetics       Date:  2001-01       Impact factor: 4.562

2.  Stem-loop 1 of the U1 snRNP plays a critical role in the suppression of HIV-1 polyadenylation.

Authors:  M P Ashe; A Furger; N J Proudfoot
Journal:  RNA       Date:  2000-02       Impact factor: 4.942

3.  Antisense promoter of human L1 retrotransposon drives transcription of adjacent cellular genes.

Authors:  M Speek
Journal:  Mol Cell Biol       Date:  2001-03       Impact factor: 4.272

4.  Transcriptional termination and coupled polyadenylation in vitro.

Authors:  M Yonaha; N J Proudfoot
Journal:  EMBO J       Date:  2000-07-17       Impact factor: 11.598

5.  Intergenic transcription in the human beta-globin gene cluster.

Authors:  K E Plant; S J Routledge; N J Proudfoot
Journal:  Mol Cell Biol       Date:  2001-10       Impact factor: 4.272

6.  Transcriptional interference by independently regulated genes occurs in any relative arrangement of the genes and is influenced by chromosomal integration position.

Authors:  Susan K Eszterhas; Eric E Bouhassira; David I K Martin; Steven Fiering
Journal:  Mol Cell Biol       Date:  2002-01       Impact factor: 4.272

Review 7.  Formation of mRNA 3' ends in eukaryotes: mechanism, regulation, and interrelationships with other steps in mRNA synthesis.

Authors:  J Zhao; L Hyman; C Moore
Journal:  Microbiol Mol Biol Rev       Date:  1999-06       Impact factor: 11.056

8.  Transcription of the human U2 snRNA genes continues beyond the 3' box in vivo.

Authors:  P Cuello; D C Boyd; M J Dye; N J Proudfoot; S Murphy
Journal:  EMBO J       Date:  1999-05-17       Impact factor: 11.598

9.  A mutation in GRS1, a glycyl-tRNA synthetase, affects 3'-end formation in Saccharomyces cerevisiae.

Authors:  C Magrath; L E Hyman
Journal:  Genetics       Date:  1999-05       Impact factor: 4.562

Review 10.  Chemically regulated expression systems and their applications in transgenic plants.

Authors:  Renhou Wang; Xiaofu Zhou; Xingzhi Wang
Journal:  Transgenic Res       Date:  2003-10       Impact factor: 2.788

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.